BioNano Genomics (BNGO) Q4 2023 Earnings Report
MX:BNGO Q4 2023 EPS Results
- Actual EPS
- -MXN 1,256.79
- Consensus EPS
- -MXN 981.40
- Beat/Miss
- Missed by -MXN 275.38
- One Year Ago EPS
- -MXN 1,465.31
MX:BNGO Q4 2023 Revenue Results
- Actual Revenue
- MXN 201.41M
- Expected Revenue
- MXN 198.23M
- Beat/Miss
- Beat by +MXN 3.17M
- YoY Revenue Growth
- +30.51%
Earnings Announcement Details
- Quarter
- Q4 2023
- Date
- 03/05/2024
- Time
- After Close
- Conference Call
- Tuesday, March 5, 2024
MX:BNGO Upcoming Earnings
BioNano Genomics's next earnings date is estimated for November 10, 2026, based on past reporting schedules.
Q4 2023 Earnings Call Audio
MX:BNGO Q4 2023 Earnings Call
0:00 / 0:00
Q4 2023 Earnings Slide Deck
No slide deck is available for this earnings event.
Q4 2023 Earnings Call Summary
No earnings call summary is available for this earnings event.
MX:BNGO Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 10, 2026 | 2026 (Q3) | -8.45- | -38.32 | ― | ― |
| Aug 10, 2026 | 2026 (Q2) | -12.59-12.40 | -37.57 | 67.00% (+25.17) | |
| May 13, 2026 | 2026 (Q1) | -16.53-14.28 | -21.6 | 33.91% (+7.33) | |
| Mar 23, 2026 | 2025 (Q4) | -46.50-29.12 | -227.97 | 87.23% (+198.85) | |
| Nov 13, 2025 | 2025 (Q3) | -38.98-38.32 | -586.12 | 93.46% (+547.80) | |
| Aug 14, 2025 | 2025 (Q2) | -49.91-37.57 | -270.52 | 86.11% (+232.95) | |
| May 14, 2025 | 2025 (Q1) | ―- | -676.3 | ― | |
| Mar 31, 2025 | 2024 (Q4) | -56.79-21.60 | -676.3 | 96.81% (+654.69) | |
| Nov 13, 2024 | 2024 (Q3) | -222.63-586.12 | -3629.46 | 83.85% (+3043.34) | |
| Aug 07, 2024 | 2024 (Q2) | -468.11-270.52 | -1397.68 | 80.65% (+1127.16) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed